Concepedia

Christopher M. Yates

CM

25

Publications

11.7K

Citations

20

H-Index

2004

Active since

Affiliations

Viamet Pharmaceuticals (United States)(Current)

University of North Carolina at Chapel Hill

The University of Texas Health Science Center at San Antonio

Imperial College London

National Institutes of Health

Christopher M. Yates is an author at Viamet Pharmaceuticals (United States) specializing in natural sciences, medicine, and biomolecular engineering.

ORCID

Top concepts

Publications per year

2004–2023

25

Publications

25

The Phyre2 web portal for protein modeling, prediction and analysis

Lawrence A. Kelley, Stefans Mezulis, Christopher M. Yates et al. · Nature Protocols · 2015 · 10K citations · Full text

, , +13

SuSPect: Enhanced Prediction of Single Amino Acid Variant (SAV) Phenotype Using Network Features

Christopher M. Yates, Ioannis Filippis, Lawrence A. Kelley et al. · Journal of Molecular Biology · 2014 · 260 citations · Full text

The interaction of PRC2 with RNA or chromatin is mutually antagonistic

Manuel Beltrán, Christopher M. Yates, Lenka Skalska et al. · Genome Research · 2016 · 234 citations · Full text

Design and optimization of highly-selective fungal CYP51 inhibitors

William J. Hoekstra, Edward P. Garvey, William R. Moore et al. · Bioorganic & Medicinal Chemistry Letters · 2014 · 179 citations · Full text

, , +5

Optimization of Cellular Activity of G9a Inhibitors 7-Aminoalkoxy-quinazolines

Feng Liu, Dalia Baršytė-Lovejoy, Abdellah Allali‐Hassani et al. · Journal of Medicinal Chemistry · 2011 · 155 citations · Full text

, , +16

Rows per page

1–5 of 25